← FDA Drug Approvals (Drugs@FDA)
RELISTOR
NDA · New Drug Application · Sponsor: SALIX · Approved 2016-07-19
Drug application
- FDA Application #
NDA208271- Application type
- New Drug Application
- Brand name
- RELISTOR
- Generic name
- METHYLNALTREXONE BROMIDE
- Active ingredients
- METHYLNALTREXONE BROMIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SALIX
- Manufacturer
- Salix Pharmaceuticals, Inc.
- First approval
- 2016-07-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown